
    
      Patients who have planned lobar radioembolization (TheraSphere (TS)) and consent to this
      study will have peripheral blood samples collected pre-TS, post-TS, 4 hours post-TS, 24 hours
      post-TS, 3 days post-TS, 7 days post-TS and 30 days post-TS to analyze specific angiogenic,
      inflammatory and immune profiles.
    
  